nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—ADRA1B—vas deferens—urinary bladder cancer	0.183	0.264	CbGeAlD
Promazine—CHRM3—ureter—urinary bladder cancer	0.0856	0.124	CbGeAlD
Promazine—CHRM3—muscle of abdomen—urinary bladder cancer	0.0616	0.089	CbGeAlD
Promazine—CYP3A4—Thiotepa—urinary bladder cancer	0.0321	0.276	CbGbCtD
Promazine—CYP2C19—urine—urinary bladder cancer	0.0259	0.0374	CbGeAlD
Promazine—CYP1A2—urine—urinary bladder cancer	0.0211	0.0305	CbGeAlD
Promazine—CYP2C9—urine—urinary bladder cancer	0.02	0.029	CbGeAlD
Promazine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0199	0.171	CbGbCtD
Promazine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0179	0.154	CbGbCtD
Promazine—CYP1A2—Etoposide—urinary bladder cancer	0.0166	0.143	CbGbCtD
Promazine—HTR2A—urine—urinary bladder cancer	0.0165	0.0239	CbGeAlD
Promazine—ADRA1D—prostate gland—urinary bladder cancer	0.016	0.0231	CbGeAlD
Promazine—CYP3A4—urine—urinary bladder cancer	0.0153	0.0221	CbGeAlD
Promazine—CYP2C9—Cisplatin—urinary bladder cancer	0.0152	0.131	CbGbCtD
Promazine—CHRM5—epithelium—urinary bladder cancer	0.0131	0.019	CbGeAlD
Promazine—CHRM2—prostate gland—urinary bladder cancer	0.0123	0.0177	CbGeAlD
Promazine—ADRA1D—epithelium—urinary bladder cancer	0.0117	0.0169	CbGeAlD
Promazine—CHRM1—prostate gland—urinary bladder cancer	0.0112	0.0161	CbGeAlD
Promazine—ADRA1B—renal system—urinary bladder cancer	0.0111	0.0161	CbGeAlD
Promazine—ADRA1D—urethra—urinary bladder cancer	0.0107	0.0154	CbGeAlD
Promazine—CHRM3—prostate gland—urinary bladder cancer	0.00998	0.0144	CbGeAlD
Promazine—ADRA1A—prostate gland—urinary bladder cancer	0.00917	0.0132	CbGeAlD
Promazine—ADRA1D—female reproductive system—urinary bladder cancer	0.00871	0.0126	CbGeAlD
Promazine—CYP3A4—Etoposide—urinary bladder cancer	0.0087	0.0748	CbGbCtD
Promazine—HRH1—prostate gland—urinary bladder cancer	0.0071	0.0103	CbGeAlD
Promazine—CHRM3—smooth muscle tissue—urinary bladder cancer	0.00707	0.0102	CbGeAlD
Promazine—ADRA2A—prostate gland—urinary bladder cancer	0.00697	0.0101	CbGeAlD
Promazine—CHRM3—renal system—urinary bladder cancer	0.00681	0.00983	CbGeAlD
Promazine—ADRA1A—epithelium—urinary bladder cancer	0.00674	0.00973	CbGeAlD
Promazine—CHRM3—urethra—urinary bladder cancer	0.00668	0.00966	CbGeAlD
Promazine—Benzphetamine—POR—urinary bladder cancer	0.00665	0.359	CrCbGaD
Promazine—HTR2C—female reproductive system—urinary bladder cancer	0.00645	0.00932	CbGeAlD
Promazine—ADRA1A—renal system—urinary bladder cancer	0.00625	0.00903	CbGeAlD
Promazine—CHRM1—female reproductive system—urinary bladder cancer	0.00609	0.0088	CbGeAlD
Promazine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00594	0.051	CbGbCtD
Promazine—ADRA2A—seminal vesicle—urinary bladder cancer	0.0059	0.00852	CbGeAlD
Promazine—Carbamazepine—UGT2B7—urinary bladder cancer	0.0057	0.308	CrCbGaD
Promazine—CHRM3—female reproductive system—urinary bladder cancer	0.00545	0.00787	CbGeAlD
Promazine—HRH1—epithelium—urinary bladder cancer	0.00521	0.00753	CbGeAlD
Promazine—CYP1A2—renal system—urinary bladder cancer	0.00517	0.00746	CbGeAlD
Promazine—HRH1—smooth muscle tissue—urinary bladder cancer	0.00502	0.00726	CbGeAlD
Promazine—HRH1—urethra—urinary bladder cancer	0.00475	0.00686	CbGeAlD
Promazine—ADRA2A—urethra—urinary bladder cancer	0.00467	0.00674	CbGeAlD
Promazine—CYP2C19—vagina—urinary bladder cancer	0.00458	0.00662	CbGeAlD
Promazine—HTR2A—epithelium—urinary bladder cancer	0.00435	0.00629	CbGeAlD
Promazine—HTR2A—smooth muscle tissue—urinary bladder cancer	0.0042	0.00606	CbGeAlD
Promazine—HTR2A—renal system—urinary bladder cancer	0.00404	0.00584	CbGeAlD
Promazine—CYP2C9—female reproductive system—urinary bladder cancer	0.00393	0.00567	CbGeAlD
Promazine—HRH1—female reproductive system—urinary bladder cancer	0.00387	0.0056	CbGeAlD
Promazine—ADRA2A—female reproductive system—urinary bladder cancer	0.0038	0.0055	CbGeAlD
Promazine—CYP3A4—renal system—urinary bladder cancer	0.00374	0.0054	CbGeAlD
Promazine—HRH1—vagina—urinary bladder cancer	0.0035	0.00506	CbGeAlD
Promazine—ADRA2A—vagina—urinary bladder cancer	0.00344	0.00497	CbGeAlD
Promazine—HTR2A—female reproductive system—urinary bladder cancer	0.00324	0.00467	CbGeAlD
Promazine—CYP3A4—female reproductive system—urinary bladder cancer	0.00299	0.00433	CbGeAlD
Promazine—HTR2A—vagina—urinary bladder cancer	0.00293	0.00423	CbGeAlD
Promazine—Clomipramine—GSTP1—urinary bladder cancer	0.0025	0.135	CrCbGaD
Promazine—HRH1—lymph node—urinary bladder cancer	0.00227	0.00327	CbGeAlD
Promazine—Tamoxifen—ESR2—urinary bladder cancer	0.00226	0.122	CrCbGaD
Promazine—ADRA2A—lymph node—urinary bladder cancer	0.00223	0.00322	CbGeAlD
Promazine—Tamoxifen—ESR1—urinary bladder cancer	0.00139	0.0753	CrCbGaD
Promazine—HTR2C—Signaling Pathways—ERBB2—urinary bladder cancer	2.69e-05	0.000156	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.69e-05	0.000155	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.69e-05	0.000155	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—EGFR—urinary bladder cancer	2.69e-05	0.000155	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—EP300—urinary bladder cancer	2.69e-05	0.000155	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—PTEN—urinary bladder cancer	2.68e-05	0.000155	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	2.68e-05	0.000155	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—MMP9—urinary bladder cancer	2.66e-05	0.000154	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—CDKN1A—urinary bladder cancer	2.65e-05	0.000153	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	2.65e-05	0.000153	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—PTEN—urinary bladder cancer	2.65e-05	0.000153	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—KRAS—urinary bladder cancer	2.63e-05	0.000152	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—SRC—urinary bladder cancer	2.61e-05	0.000151	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—KRAS—urinary bladder cancer	2.59e-05	0.00015	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—KRAS—urinary bladder cancer	2.59e-05	0.000149	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—KRAS—urinary bladder cancer	2.58e-05	0.000149	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—ERBB2—urinary bladder cancer	2.58e-05	0.000149	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—KRAS—urinary bladder cancer	2.57e-05	0.000149	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—RHOA—urinary bladder cancer	2.57e-05	0.000148	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.56e-05	0.000148	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—EP300—urinary bladder cancer	2.56e-05	0.000148	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CXCL8—urinary bladder cancer	2.55e-05	0.000148	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—KRAS—urinary bladder cancer	2.54e-05	0.000147	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CREBBP—urinary bladder cancer	2.54e-05	0.000147	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—KRAS—urinary bladder cancer	2.54e-05	0.000147	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—HRAS—urinary bladder cancer	2.54e-05	0.000147	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—RHOA—urinary bladder cancer	2.53e-05	0.000146	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—EP300—urinary bladder cancer	2.53e-05	0.000146	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—RHOA—urinary bladder cancer	2.52e-05	0.000146	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	2.52e-05	0.000146	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—RHOA—urinary bladder cancer	2.51e-05	0.000145	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IGF1—urinary bladder cancer	2.51e-05	0.000145	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—RHOA—urinary bladder cancer	2.5e-05	0.000145	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—EGFR—urinary bladder cancer	2.5e-05	0.000144	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—SRC—urinary bladder cancer	2.49e-05	0.000144	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—PTGS2—urinary bladder cancer	2.49e-05	0.000144	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—RHOA—urinary bladder cancer	2.48e-05	0.000143	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—MYC—urinary bladder cancer	2.48e-05	0.000143	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—RHOA—urinary bladder cancer	2.47e-05	0.000143	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	2.46e-05	0.000142	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—SRC—urinary bladder cancer	2.46e-05	0.000142	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.45e-05	0.000142	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CXCL8—urinary bladder cancer	2.44e-05	0.000141	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—MYC—urinary bladder cancer	2.44e-05	0.000141	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—IL2—urinary bladder cancer	2.44e-05	0.000141	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	2.44e-05	0.000141	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	2.44e-05	0.000141	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—HRAS—urinary bladder cancer	2.43e-05	0.00014	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—EGFR—urinary bladder cancer	2.42e-05	0.00014	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—EGFR—urinary bladder cancer	2.39e-05	0.000138	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CCND1—urinary bladder cancer	2.38e-05	0.000138	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	2.38e-05	0.000137	CbGpPWpGaD
Promazine—CHRM3—Metabolism—PTEN—urinary bladder cancer	2.36e-05	0.000137	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—KRAS—urinary bladder cancer	2.36e-05	0.000136	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—MYC—urinary bladder cancer	2.34e-05	0.000135	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	2.34e-05	0.000135	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL2—urinary bladder cancer	2.34e-05	0.000135	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	2.33e-05	0.000135	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	2.33e-05	0.000135	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—ERBB2—urinary bladder cancer	2.33e-05	0.000134	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—ERBB2—urinary bladder cancer	2.32e-05	0.000134	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MMP9—urinary bladder cancer	2.31e-05	0.000133	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CDKN1A—urinary bladder cancer	2.3e-05	0.000133	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—RHOA—urinary bladder cancer	2.3e-05	0.000133	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—PTEN—urinary bladder cancer	2.3e-05	0.000133	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—ERBB2—urinary bladder cancer	2.3e-05	0.000133	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	2.29e-05	0.000132	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—ERBB2—urinary bladder cancer	2.29e-05	0.000132	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—EGFR—urinary bladder cancer	2.29e-05	0.000132	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—KRAS—urinary bladder cancer	2.29e-05	0.000132	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CCND1—urinary bladder cancer	2.28e-05	0.000132	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—KRAS—urinary bladder cancer	2.26e-05	0.000131	CbGpPWpGaD
Promazine—CHRM3—Metabolism—EP300—urinary bladder cancer	2.25e-05	0.00013	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	2.25e-05	0.00013	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.24e-05	0.000129	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	2.24e-05	0.000129	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—MYC—urinary bladder cancer	2.23e-05	0.000129	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	2.22e-05	0.000128	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	2.21e-05	0.000128	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MMP9—urinary bladder cancer	2.21e-05	0.000128	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CXCL8—urinary bladder cancer	2.21e-05	0.000127	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	2.2e-05	0.000127	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CDKN1A—urinary bladder cancer	2.2e-05	0.000127	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—MYC—urinary bladder cancer	2.2e-05	0.000127	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CXCL8—urinary bladder cancer	2.2e-05	0.000127	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	2.2e-05	0.000127	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—PTEN—urinary bladder cancer	2.2e-05	0.000127	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—HRAS—urinary bladder cancer	2.19e-05	0.000127	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—EP300—urinary bladder cancer	2.19e-05	0.000127	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—HRAS—urinary bladder cancer	2.18e-05	0.000126	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—EGFR—urinary bladder cancer	2.18e-05	0.000126	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CXCL8—urinary bladder cancer	2.18e-05	0.000126	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	2.17e-05	0.000125	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—PTEN—urinary bladder cancer	2.17e-05	0.000125	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	2.16e-05	0.000125	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—KRAS—urinary bladder cancer	2.16e-05	0.000125	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	2.16e-05	0.000125	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL2—urinary bladder cancer	2.15e-05	0.000124	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	2.15e-05	0.000124	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—EGFR—urinary bladder cancer	2.15e-05	0.000124	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.15e-05	0.000124	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—SRC—urinary bladder cancer	2.13e-05	0.000123	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	2.13e-05	0.000123	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	2.12e-05	0.000122	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	2.11e-05	0.000122	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL2—urinary bladder cancer	2.11e-05	0.000122	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL2—urinary bladder cancer	2.1e-05	0.000121	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	2.1e-05	0.000121	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—EP300—urinary bladder cancer	2.1e-05	0.000121	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	2.08e-05	0.00012	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	2.08e-05	0.00012	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—EP300—urinary bladder cancer	2.07e-05	0.00012	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	2.07e-05	0.000119	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	2.06e-05	0.000119	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—KRAS—urinary bladder cancer	2.06e-05	0.000119	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CCND1—urinary bladder cancer	2.05e-05	0.000119	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CCND1—urinary bladder cancer	2.05e-05	0.000118	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.05e-05	0.000118	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	2.04e-05	0.000118	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—SRC—urinary bladder cancer	2.04e-05	0.000118	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	2.04e-05	0.000118	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—TP53—urinary bladder cancer	2.03e-05	0.000118	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—KRAS—urinary bladder cancer	2.03e-05	0.000118	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	2.03e-05	0.000117	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	2.03e-05	0.000117	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	2.03e-05	0.000117	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	2.02e-05	0.000117	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	2.02e-05	0.000117	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TP53—urinary bladder cancer	2.01e-05	0.000116	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	2.01e-05	0.000116	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	2e-05	0.000116	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	2e-05	0.000116	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	2e-05	0.000116	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MMP9—urinary bladder cancer	1.99e-05	0.000115	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.99e-05	0.000115	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	1.99e-05	0.000115	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	1.99e-05	0.000115	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MMP9—urinary bladder cancer	1.99e-05	0.000115	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.99e-05	0.000115	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—PTEN—urinary bladder cancer	1.98e-05	0.000115	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.98e-05	0.000115	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—PTEN—urinary bladder cancer	1.98e-05	0.000114	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	1.97e-05	0.000114	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	1.96e-05	0.000114	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.96e-05	0.000113	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	1.96e-05	0.000113	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	1.96e-05	0.000113	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	1.96e-05	0.000113	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	1.95e-05	0.000113	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—HRAS—urinary bladder cancer	1.95e-05	0.000112	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—EP300—urinary bladder cancer	1.93e-05	0.000112	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	1.93e-05	0.000111	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TP53—urinary bladder cancer	1.92e-05	0.000111	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—HRAS—urinary bladder cancer	1.92e-05	0.000111	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MYC—urinary bladder cancer	1.91e-05	0.00011	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.9e-05	0.00011	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	1.9e-05	0.00011	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	1.9e-05	0.00011	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—EP300—urinary bladder cancer	1.89e-05	0.000109	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—EP300—urinary bladder cancer	1.89e-05	0.000109	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.88e-05	0.000109	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.88e-05	0.000109	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	1.88e-05	0.000109	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SRC—urinary bladder cancer	1.88e-05	0.000109	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	1.87e-05	0.000108	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—EGFR—urinary bladder cancer	1.87e-05	0.000108	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	1.86e-05	0.000108	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	1.85e-05	0.000107	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	1.85e-05	0.000107	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SRC—urinary bladder cancer	1.84e-05	0.000106	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—HRAS—urinary bladder cancer	1.84e-05	0.000106	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SRC—urinary bladder cancer	1.83e-05	0.000106	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TP53—urinary bladder cancer	1.83e-05	0.000106	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MYC—urinary bladder cancer	1.83e-05	0.000106	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	1.82e-05	0.000105	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	1.82e-05	0.000105	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	1.82e-05	0.000105	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	1.81e-05	0.000105	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	1.81e-05	0.000105	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TP53—urinary bladder cancer	1.81e-05	0.000104	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.8e-05	0.000104	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—EGFR—urinary bladder cancer	1.79e-05	0.000103	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.77e-05	0.000102	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—KRAS—urinary bladder cancer	1.76e-05	0.000102	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.76e-05	0.000102	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—HRAS—urinary bladder cancer	1.75e-05	0.000101	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.75e-05	0.000101	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	1.73e-05	0.0001	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—HRAS—urinary bladder cancer	1.73e-05	9.99e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—KRAS—urinary bladder cancer	1.69e-05	9.76e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MYC—urinary bladder cancer	1.68e-05	9.73e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	1.68e-05	9.72e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.68e-05	9.69e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.66e-05	9.6e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	1.66e-05	9.58e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	1.65e-05	9.56e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MYC—urinary bladder cancer	1.65e-05	9.53e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	1.65e-05	9.52e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MYC—urinary bladder cancer	1.64e-05	9.5e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	1.63e-05	9.4e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	1.62e-05	9.38e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	1.62e-05	9.37e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	1.62e-05	9.35e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—EGFR—urinary bladder cancer	1.61e-05	9.32e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.61e-05	9.29e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—EGFR—urinary bladder cancer	1.61e-05	9.29e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	1.59e-05	9.2e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	1.59e-05	9.17e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TP53—urinary bladder cancer	1.57e-05	9.06e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	1.56e-05	8.99e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.54e-05	8.88e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	1.53e-05	8.85e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	1.53e-05	8.83e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—KRAS—urinary bladder cancer	1.52e-05	8.8e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—KRAS—urinary bladder cancer	1.52e-05	8.77e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	1.51e-05	8.71e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	1.5e-05	8.69e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TP53—urinary bladder cancer	1.5e-05	8.67e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	1.5e-05	8.67e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—HRAS—urinary bladder cancer	1.5e-05	8.66e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	1.47e-05	8.52e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.47e-05	8.47e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—HRAS—urinary bladder cancer	1.43e-05	8.29e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.4e-05	8.1e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	1.39e-05	8.05e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TP53—urinary bladder cancer	1.38e-05	7.99e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.37e-05	7.94e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	1.36e-05	7.87e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	1.36e-05	7.85e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TP53—urinary bladder cancer	1.35e-05	7.82e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TP53—urinary bladder cancer	1.35e-05	7.8e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.35e-05	7.79e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.34e-05	7.73e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	1.34e-05	7.72e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	1.33e-05	7.7e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	1.32e-05	7.65e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	1.3e-05	7.52e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	1.3e-05	7.51e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—HRAS—urinary bladder cancer	1.29e-05	7.48e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.29e-05	7.48e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—HRAS—urinary bladder cancer	1.29e-05	7.46e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	1.28e-05	7.39e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	1.27e-05	7.37e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	1.24e-05	7.16e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.2e-05	6.92e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	1.18e-05	6.84e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.14e-05	6.6e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.06e-05	6.13e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	9.24e-06	5.34e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.81e-06	5.09e-05	CbGpPWpGaD
